Macrocycles for Drug Discovery

Funder	European Commission
Recipient Organization	Technische Universitat Darmstadt
Country	Germany
Start Date	Nov 01, 2024
End Date	Oct 31, 2028
Duration	1,460 days
Number of Grantees	20
Roles	Associated Partner; Participant; Coordinator
Data Source	European Commission
Grant ID	`101168916`

Grant Description

Better drugs are one of the most efficient and sustainable ways to improve health care, a key strategic orientation in Horizon Europe.New drug modalities such as macrocycles are expected to be a key enabling technology for this strategic perspective.

The goal of MC4DD is to train the next generation of European medicinal chemists in a multidisciplinary environment to promote European drug discovery competitiveness, directly by advancing knowhow on macrocycles and long-term via the skills carried on by the researchers trained in the doctoral network.

All Grantees

Analyticon Discovery Gmbh; Abbvie Deutschland Gmbh & Co Kg; Universiteit Leiden; The Chancellor Masters and Scholars of the University of Cambridge; Sanofi-Aventis Deutschland Gmbh; Fidelta Doo Za Istrazivanje I Razvoj; Ukrorgsyntez Ltd; Astrazeneca Ab; Universita Degli Studi Di Torino; F. Hoffmann-la Roche Ag; Uppsala Universitet; Ecole Polytechnique Federale de Lausanne; University of York; Bayer Ag; Enamine Germany Gmbh; Eidgenoessische Technische Hochschule Zuerich; Johann Wolfgang Goethe-Universitaet Frankfurt Am Main; Technische Universitat Darmstadt; University College London; Novo Nordisk A/S